[New flu therapy. Progress or burden for the budget?].

Vogel, G E

[New flu therapy. Progress or burden for the budget?]. / Neue Grippe-Therapie. Durchbruch oder Budgetlast?

Vogel, G E.

Affiliation

Vogel GE; Arzt für Innere Medizin, Gastroenterologie/Nephrologie, München.

MMW Fortschr Med ; 142(8): 14, 2000 Feb 24.

Article in De | MEDLINE | ID: mdl-10810861

Subject(s)

Acetamides/therapeutic use; Antiviral Agents/therapeutic use; Influenza, Human/drug therapy; Sialic Acids/therapeutic use; Acetamides/adverse effects; Acetamides/economics; Antiviral Agents/adverse effects; Antiviral Agents/economics; Cost-Benefit Analysis; Guanidines; Humans; Influenza, Human/economics; Neuraminidase/antagonists & inhibitors; Oseltamivir; Pyrans; Sialic Acids/adverse effects; Sialic Acids/economics; Zanamivir

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Sialic Acids / Influenza, Human / Acetamides Type of study: Health_economic_evaluation Limits: Humans Language: De Journal: MMW Fortschr Med Journal subject: MEDICINA Year: 2000 Document type: Article Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links